Search

everythinglearnresearchcommunity

for

Search:↓

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Blocking TRPV3 may help treat itch in dry skin conditions.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

PTH-CBD agonists may help regrow hair after chemotherapy.

TRH in hair follicles can influence hair color by increasing melanin.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Serotonin helps wounds heal faster.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Blocking a protein called prostaglandin D2 might help treat hair loss.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Using a certain drug on the skin can help prevent hair loss caused by pulling on the hair.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Injecting patients' own PRP into their thyroid improved thyroid function and symptoms in most hypothyroidism cases.

TRPV4 slows hair growth by affecting hair follicle cells.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

CRH causes hair loss by reducing cell survival in hair follicles.